What is it about?

There is a robust and positive relationship between patent originality and quality in the pharmaceutical sector, which is positively moderated by joint patent ownership with a university. Policymakers can use characteristics of the originality of a new drug to discern the optimal length of market exclusivity needed to enable the innovator to recoup expenditures related to research and development.

Featured Image

Read the Original

This page is a summary of: Prescribing originality: investigating the impact of original knowledge on patent quality in the pharmaceutical sector, Journal of Entrepreneurship and Public Policy, February 2021, Emerald,
DOI: 10.1108/jepp-09-2020-0071.
You can read the full text:

Read

Contributors

The following have contributed to this page